GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | 8/14/2026 4:14:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $7,877,000 +166.7% | Assets $30,707,000 | EPS -$24.14 | |
| Cue Biopharma, Inc. (CUE) | 8/14/2026 4:12:10 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $7,877,000 +166.7% | Assets $30,707,000 | EPS -$24.14 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 5/21/2026 8:53:16 AM | View | Proxy | SEC | Y 2025 | ||||||
| Cue Biopharma, Inc. (CUE) | 5/14/2026 4:22:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $5,686,000 +1,250.6% | Assets $30,877,000 | EPS -$1.08 | |
| Cue Biopharma, Inc. (CUE) | 5/14/2026 4:20:01 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $5,686,000 +1,250.6% | Assets $30,877,000 | EPS -$1.08 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 3/16/2026 4:14:14 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $27,466,000 +195.7% | Assets $42,212,000 | EPS -$0.28 | |
| Cue Biopharma, Inc. (CUE) | 3/16/2026 4:02:00 PM | View | Proxy | SEC | Y 2025 | ||||||
| Cue Biopharma, Inc. (CUE) | 3/16/2026 4:01:47 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $21,942,000 +1,292.3% | Assets $42,212,000 | EPS $0.03 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 11/12/2025 4:16:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $2,149,000 -35.6% | Assets $31,644,000 | EPS -$0.07 | |
| Cue Biopharma, Inc. (CUE) | 11/12/2025 4:01:32 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $2,149,000 -35.6% | Assets $31,644,000 | EPS -$0.07 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/12/2025 4:13:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $2,954,000 +11.1% | Assets $40,707,000 | EPS -$0.09 | |
| Cue Biopharma, Inc. (CUE) | 8/12/2025 4:01:33 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $2,954,000 +11.1% | Assets $40,707,000 | EPS -$0.09 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 5/12/2025 4:13:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $421,000 -75.5% | Assets $22,254,000 | EPS -$0.17 | |
| Cue Biopharma, Inc. (CUE) | 5/12/2025 4:01:52 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $421,000 -75.5% | Assets $22,254,000 | EPS -$0.17 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 4/25/2025 4:02:52 PM | View | Proxy | SEC | Y 2024 | ||||||
| Cue Biopharma, Inc. (CUE) | 3/31/2025 4:16:14 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $9,287,000 +69.2% | Assets $32,191,000 | EPS -$0.72 | |
| Cue Biopharma, Inc. (CUE) | 3/31/2025 4:02:13 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $1,576,000 -13.5% | Assets $32,191,000 | EPS -$0.10 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 11/14/2024 4:14:35 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $3,336,000 +58.9% | Assets $44,810,000 | EPS -$0.17 | |
| Cue Biopharma, Inc. (CUE) | 11/14/2024 4:01:39 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $3,336,000 +58.9% | Assets $44,810,000 | EPS -$0.17 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 9/10/2024 4:01:05 PM | View | Proxy | SEC | Y 2023 | ||||||
| Cue Biopharma, Inc. (CUE) | 8/19/2024 4:06:57 PM | View | Financials | Earnings | WIRE | 2Q 2024 | Rev $2,658,000 +92.3% | Assets $42,329,000 | EPS -$0.20 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/14/2024 4:19:30 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $2,658,000 +92.3% | Assets $42,329,000 | EPS -$0.20 | |
| Cue Biopharma, Inc. (CUE) | 5/9/2024 4:15:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $1,717,000 +818.2% | Assets $53,951,000 | EPS -$0.25 | |
| Cue Biopharma, Inc. (CUE) | 5/9/2024 4:02:48 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $1,717,000 +818.2% | Assets $53,951,000 | EPS -$0.25 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 4/26/2024 4:09:11 PM | View | Proxy | SEC | Y 2023 | ||||||
| Cue Biopharma, Inc. (CUE) | 4/8/2024 4:06:01 PM | View | Financials | Earnings | WIRE | 1Q 2024 | Rev $1,717,000 +818.2% | Assets $53,951,000 | EPS -$0.25 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 3/28/2024 4:58:53 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $5,490,000 +341.0% | Assets $61,530,000 | EPS -$1.11 | |
| Cue Biopharma, Inc. (CUE) | 11/9/2023 4:08:12 PM | View | Financials | Earnings | WIRE | 3Q 2023 | Rev $2,100,000 +2,988.2% | Assets $68,888,000 | EPS -$0.24 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 11/3/2023 4:29:15 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $2,100,000 +2,988.2% | Assets $68,888,000 | EPS -$0.24 | |
| Cue Biopharma, Inc. (CUE) | 8/9/2023 4:12:12 PM | View | Financials | Earnings | WIRE | 2Q 2023 | Rev $1,382,000 +5,215.4% | Assets $73,163,000 | EPS -$0.29 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/8/2023 4:20:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $1,382,000 +5,215.4% | Assets $73,163,000 | EPS -$0.29 | |
| Cue Biopharma, Inc. (CUE) | 5/9/2023 4:36:03 PM | View | Financials | Earnings | WIRE | 1Q 2023 | Rev $187,000 -81.3% | Assets $81,682,000 | EPS -$0.29 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 5/9/2023 4:23:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $187,000 -81.3% | Assets $81,682,000 | EPS -$0.29 | |
| Cue Biopharma, Inc. (CUE) | 4/28/2023 4:09:11 PM | View | Proxy | SEC | Y 2022 | ||||||
| Cue Biopharma, Inc. (CUE) | 3/21/2023 4:19:41 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $1,245,000 -91.7% | Assets $91,283,000 | EPS -$1.49 | |
| Cue Biopharma, Inc. (CUE) | 3/21/2023 4:12:16 PM | View | Financials | Earnings | WIRE | Y 2022 | Rev $151,000 -98.2% | Assets $91,283,000 | EPS -$0.38 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 11/14/2022 4:26:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $68,000 -97.2% | Assets $76,300,000 | EPS -$0.31 | |
| Cue Biopharma, Inc. (CUE) | 11/14/2022 4:03:01 PM | View | Financials | Earnings | WIRE | 3Q 2022 | Rev $68,000 -97.2% | Assets $76,300,000 | EPS -$0.31 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/4/2022 4:31:33 PM | View | Financials | Earnings | WIRE | 2Q 2022 | Rev $26,000 -99.1% | Assets $84,749,000 | EPS -$0.37 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/4/2022 4:26:49 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $26,000 -99.1% | Assets $84,749,000 | EPS -$0.37 | |
| Cue Biopharma, Inc. (CUE) | 5/10/2022 4:39:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $1,000,000 -35.6% | Assets $90,704,000 | EPS -$0.44 | |
| Cue Biopharma, Inc. (CUE) | 5/10/2022 4:31:30 PM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $1,000,000 -35.6% | Assets $90,704,000 | EPS -$0.44 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 4/29/2022 4:03:17 PM | View | Proxy | SEC | Y 2021 | ||||||
| Cue Biopharma, Inc. (CUE) | 3/16/2022 5:32:38 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $14,941,370 +373.7% | Assets $83,400,935 | EPS -$1.41 | |
| Cue Biopharma, Inc. (CUE) | 11/9/2021 4:44:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $2,395,000 +240.2% | Assets $78,875,000 | EPS -$0.41 | |
| Cue Biopharma, Inc. (CUE) | 8/17/2021 4:02:34 PM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $2,739,000 +154.8% | Assets $89,672,000 | EPS -$0.33 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/9/2021 4:12:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $2,739,000 +154.8% | Assets $89,672,000 | EPS -$0.33 | |
| Cue Biopharma, Inc. (CUE) | 5/17/2021 4:02:25 PM | View | Financials | Earnings | WIRE | 1Q 2021 | Rev $1,553,000 +72.6% | Assets $88,721,000 | EPS -$0.41 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 5/10/2021 4:13:15 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $1,553,000 +72.6% | Assets $88,721,000 | EPS -$0.41 | |
| Cue Biopharma, Inc. (CUE) | 4/26/2021 4:01:31 PM | View | Proxy | SEC | Y 2020 | ||||||
| Cue Biopharma, Inc. (CUE) | 3/16/2021 4:03:20 PM | View | Financials | Earnings | WIRE | Y 2020 | Rev $475,325 -54.7% | Assets $99,533,800 | EPS -$0.36 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 3/9/2021 4:53:53 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $3,154,325 -8.8% | Assets $99,533,800 | EPS -$1.56 | |
| Cue Biopharma, Inc. (CUE) | 11/17/2020 4:02:03 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $704,000 -28.5% | Assets $106,617,000 | EPS -$0.34 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 11/9/2020 4:16:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $704,000 -28.5% | Assets $106,617,000 | EPS -$0.34 | |
| Cue Biopharma, Inc. (CUE) | 8/31/2020 4:02:22 PM | View | Financials | Earnings | WIRE | 2Q 2020 | Rev $1,075,000 +1.9% | Assets $101,353,000 | EPS -$0.38 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 8/10/2020 6:13:14 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $1,075,000 +1.9% | Assets $101,353,000 | EPS -$0.38 | |
| Cue Biopharma, Inc. (CUE) | 5/29/2020 4:08:33 PM | View | Proxy | SEC | Y 2019 | ||||||
| Cue Biopharma, Inc. (CUE) | 5/19/2020 4:08:10 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $900,000 +143.2% | Assets $60,649,000 | EPS -$0.48 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 5/7/2020 4:24:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $900,000 +143.2% | Assets $60,649,000 | EPS -$0.48 | |
| Cue Biopharma, Inc. (CUE) | 3/17/2020 4:24:17 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $1,049,331 +217.4% | Assets $71,605,009 | EPS -$0.36 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 3/12/2020 6:12:11 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $3,458,331 +202.7% | Assets $71,605,009 | EPS -$1.66 | |
| Cue Biopharma, Inc. (CUE) | 11/12/2019 4:06:36 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $984,000 +119.2% | Assets $45,209,000 | EPS -$0.31 | Export Earnings Model | |
| Cue Biopharma, Inc. (CUE) | 11/7/2019 4:40:28 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $984,000 +119.2% | Assets $45,209,000 | EPS -$0.31 | |
| Cue Biopharma, Inc. (CUE) | 8/8/2019 4:37:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $1,055,000 +513.4% | Assets $41,756,000 | EPS -$0.46 | |
| Cue Biopharma, Inc. (CUE) | 5/8/2019 5:08:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $370,000 | Assets $45,188,000 | EPS -$0.54 | |
| Cue Biopharma, Inc. (CUE) | 3/14/2019 4:37:02 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,142,604 | Assets $45,363,100 | EPS -$1.94 | |
| Cue Biopharma, Inc. (CUE) | 11/13/2018 4:37:42 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $449,000 | Assets $44,582,000 | EPS -$0.62 | |
| Cue Biopharma, Inc. (CUE) | 8/13/2018 5:07:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $172,000 | Assets $53,114,000 | EPS -$0.36 | |
| Cue Biopharma, Inc. (CUE) | 5/14/2018 5:29:30 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $59,326,000 | EPS -$0.37 | ||
| Cue Biopharma, Inc. (CUE) | 4/30/2018 4:22:39 PM | View | Proxy | SEC | Y 2017 |